# Ectopic Pregnancy

- Implantation of the **fertilized ovum outside the uterine cavity**
- Most common site: **ampullary portion** of fallopian tube

## Common Sites of Ectopic Pregnancy

| Site               | Frequency (%)                          |
| ------------------ | -------------------------------------- |
| **Fallopian tube** | \~95% (ampullary > isthmic > fimbrial) |
| **Ovary**          | 0.5–1%                                 |
| **Cervix**         | \<1%                                   |
| **Abdominal**      | \~1%                                   |
| **Cesarean scar**  | Increasingly reported                  |

## Risk Factors

1. **Tubal damage**: PID, tubal surgery, sterilization
2. **Previous ectopic pregnancy**
3. **IVF or ART**
4. **Smoking**
5. **Intrauterine device (IUD)** in situ
6. **Congenital tubal anomalies**

## Clinical Features

| Feature                        | Description                                          |
| ------------------------------ | ---------------------------------------------------- |
| **Amenorrhoea**                | Typically **6–8 weeks** from LMP                     |
| **Abdominal pain**             | **Lower abdominal pain** (unilateral or generalized) |
| **Vaginal bleeding**           | Usually **light spotting**                           |
| **Shoulder tip pain**          | If **intraperitoneal bleeding** irritates diaphragm  |
| **Dizziness or collapse**      | Suggests **rupture** → hypovolemia                   |
| **Adnexal tenderness or mass** | On bimanual exam                                     |
| **Cervical motion tenderness** | Classic finding in pelvic exam                       |

> ⚠️ Always suspect ectopic in **reproductive-aged woman** with **amenorrhoea + abdominal pain ± bleeding**

## Investigations

### A. For Diagnosis

#### 1. Urine/Serum Pregnancy Test

- **β-hCG positive** but typically **lower than expected** for gestational age
- Does **not exclude ectopic**

#### 2. Transvaginal Ultrasound (TVUS)

- **No intrauterine gestational sac** + β-hCG >1500 IU/L (discriminatory zone) → suspect ectopic
- May see:

  - **Adnexal mass or ring**
  - **Free fluid** in pouch of Douglas (suggests rupture)
  - **Pseudogestational sac** in uterus (misleading)

#### 3. Serial β-hCG Measurements

- In normal IUP: hCG **doubles every 48–72 hrs**
- In ectopic: hCG **rises slowly, plateaus or falls**

### B. For Complications or Associated Risks

- **CBC** → assess for **anemia or blood loss**
- **Group and crossmatch** → if surgical or rupture suspected
- **LFT/RFT** → pre-op workup
- **Progesterone level** (optional) → \<5 ng/mL suggests nonviable pregnancy

## Complications

### A. Early Complications

| Complication             | Mechanism                                         |
| ------------------------ | ------------------------------------------------- |
| **Tubal rupture**        | Most dangerous → massive intraperitoneal bleeding |
| **Hemorrhagic shock**    | Due to rupture and blood loss                     |
| **Infection**            | If secondary infection of retained tissue         |
| **Pain and infertility** | Due to scarring and adhesions                     |

### B. Long-term Complications

| Complication                    | Mechanism                                |
| ------------------------------- | ---------------------------------------- |
| **Infertility**                 | Tubal damage, adhesions                  |
| **Recurrent ectopic pregnancy** | Risk increases after 1st ectopic (\~10%) |
| **Chronic pelvic pain**         | Due to tubal scarring                    |

<details>
<summary>Summary of Key Diagnostic Points</summary>

| Tool                                   | Finding                                       |
| -------------------------------------- | --------------------------------------------- |
| **β-hCG >1500 + empty uterus on TVUS** | Suggests ectopic                              |
| **Adnexal mass + free fluid**          | Likely ruptured ectopic                       |
| **Slow-rising β-hCG**                  | Non-viable pregnancy (ectopic or miscarriage) |

</details>

## Management of Ectopic Pregnancy

> Depends on **clinical stability**, **size of ectopic**, **β-hCG level**, **future fertility desire**, and **rupture status**

### I. Emergency Management (if ruptured or unstable)

#### A. Airway & B. Breathing

- Ensure patent airway
- Administer high-flow oxygen

#### C. Circulation

- **IV access (2 large-bore cannulas)**
- Send blood for:

  - CBC, group & crossmatch
  - Coagulation profile

- Begin **IV fluids (normal saline or Ringer’s lactate)**
- Prepare for **urgent blood transfusion** if needed

#### D. Definitive Management

- **Emergency laparotomy** or **laparoscopy**:

  - **Salpingectomy** if tube ruptured
  - May attempt **salpingostomy** if fertility preservation is crucial and tube intact

#### E. Evaluate

- Check for other pathology, assess contralateral tube
- β-hCG baseline for follow-up

#### F. Follow-up

- Serial **β-hCG monitoring** until undetectable
- Counseling: future ectopic risk, contraception, fertility planning

---

### II. Definitive Management (Stable Patients)

#### A. Expectant Management

> For **selected stable, asymptomatic women**

**Criteria:**

- β-hCG \<1500 IU/L and falling
- No fetal cardiac activity
- No significant free fluid
- Adnexal mass \<3.5 cm

**Monitoring:**

- Serial **β-hCG** every 48–72 hrs then weekly
- Avoid intercourse, strenuous activity
- If β-hCG plateaus or rises → switch to active management

#### B. Medical Management → Methotrexate

- Single-dose protocol: `Methotrexate 50 mg/m² IM`

##### Eligibility Criteria:

- Hemodynamically **stable**
- No significant pain
- No fetal cardiac activity
- **β-hCG \<5000 IU/L**
- Adnexal mass **\<3.5 cm**
- No hepatic, renal, hematologic disease

##### Monitoring:

- β-hCG on **Day 4 and 7**

  - Should fall ≥15% → continue weekly monitoring
  - If not ↓ → 2nd dose of methotrexate

##### Side Effects:

- Nausea, mouth ulcers, abdominal pain (transient)
- Liver dysfunction, bone marrow suppression (rare)

##### Contraindications:

- Breastfeeding
- Immunodeficiency
- Liver/renal disease
- Peptic ulcer
- Ruptured ectopic

#### C. Surgical Management

##### 1. Laparoscopy (Preferred if available)

- **Salpingostomy**:

  - Removal of ectopic, tube preserved
  - Requires **close β-hCG follow-up** (risk of persistent trophoblast)

- **Salpingectomy**:

  - Removal of tube
  - Done if tube is damaged or woman has no fertility desire

##### 2. Laparotomy

- For **hemodynamically unstable** or large ruptured ectopic

---

### III. Follow-Up Care

- Serial β-hCG until **undetectable** (to rule out persistent trophoblast)
- **Rh immunoglobulin** if Rh-negative
- **Emotional support** and psychological counseling
- **Contraception**: Avoid pregnancy for **3 months** after methotrexate
- **Future fertility**: Advise early scan in next pregnancy (6 weeks) to confirm intrauterine location

<details>
<summary>Management Summary Table</summary>

| Approach                   | Indication                                          | Notes                                      |
| -------------------------- | --------------------------------------------------- | ------------------------------------------ |
| **Expectant**              | β-hCG \<1500 IU/L, decreasing, asymptomatic         | Monitor weekly                             |
| **Medical (Methotrexate)** | Stable, β-hCG \<5000, no FHR, small ectopic         | β-hCG monitoring, 15% drop from day 4 to 7 |
| **Surgical**               | Ruptured ectopic, β-hCG >5000, failed medical, pain | Laparoscopy or laparotomy                  |

</details>
